Pediatric Department, Vestfold Hospital Trust, Tønsberg, Norway.
Scand Cardiovasc J. 2010 Dec;44(6):331-6. doi: 10.3109/14017431.2010.525747. Epub 2010 Nov 11.
Our study aimed to investigate the relationship between exercise-induced pulmonary arterial hypertension and genetic changes related to the transforming growth factor-β (TGF-β) signalling pathway in patients with cardiac septal defects.
In a population-based group of 44 patients (age 13-25 years) with either isolated ventricular septal defect (n=27) or isolated atrial septal defect (n=17), right ventricular systolic pressure response to submaximal exercise was studied by echocardiography and classified as normal (≤45 mmHg), borderline (45-50 mmHg) or abnormal (>50 mmHg). Three genes related to TGF-β, bone morphogenetic protein receptor type 2 (BMPR2), activin receptor-like kinase 1 (ALK1) and endoglin (ENG), were analyzed by DNA sequencing (only BMPR2) and multiplex ligand-dependent probe amplification (BMPR2, ALK1 and ENG).
Pressure response was borderline in five and abnormal in nine patients. Five patients showed mutations in exon 12 of the bone morphogenetic protein receptor type 2 gene. The previously described polymorphism S775N (c. 2324, G > A) was found in three patients with normal pressure response. The mutation Y589C (c. 1766, A > G), which has not been described previously, was found in two of 14 patients with borderline/abnormal pressure response.
Genetic changes in the BMPR2 gene may be overrepresented in patients with cardiac septal defects and exercise-induced pulmonary hypertension.
本研究旨在探讨运动诱导性肺动脉高压与心脏间隔缺损患者转化生长因子-β(TGF-β)信号通路相关基因突变之间的关系。
在一个基于人群的 44 名患者(年龄 13-25 岁)组中,包括单纯室间隔缺损(n=27)或单纯房间隔缺损(n=17),通过超声心动图研究右心室收缩压对亚最大运动的反应,并分为正常(≤45mmHg)、临界(45-50mmHg)或异常(>50mmHg)。通过 DNA 测序(仅 BMPR2)和多重配体依赖性探针扩增(BMPR2、ALK1 和 ENG)分析了三个与 TGF-β相关的基因,骨形成蛋白受体 2 型(BMPR2)、激活素受体样激酶 1(ALK1)和内格林(ENG)。
5 名患者的压力反应为临界值,9 名患者的压力反应异常。5 名患者的骨形态发生蛋白受体 2 型基因外显子 12 发生突变。先前描述的 S775N 多态性(c.2324,G > A)在 3 名压力反应正常的患者中发现。以前未描述的 Y589C(c.1766,A > G)突变在 14 名临界/异常压力反应患者中的 2 名中发现。
BMPR2 基因突变在心脏间隔缺损和运动诱导性肺动脉高压患者中可能过度表达。